A prospective study to evaluate the axilla in cases of breast carcinoma to exclude axillary lymph node dissection in sentinel lymph node negative cases

Sentinel lymph node biopsy (SLNB) has become standard to stage the axilla in cases of clinically and Ultrasound negative avoiding unnecessary axillary Lymph dissection which is associated with higher morbidity patients 1. The Primary objective preoperatively detect metastasis USG confirmed perform Biopsy, 2. To negate need for treatment breast cancer sentinel A total number 80 core needle proved were subjected Breast axilla. who had suspicious features Guided FNAC. patient having positive (metastasis) over guided FNAC ALND those Negative Normal Axilla i.e. No SLNB using blue dye. followed up Adjuvant Chemotherapy every 3months combination sonography Mammograms, X-ray abdominal performed annually. All proven USG. From 32 metastatic deposits Rest 48 Axilla. undergone 15 showed ALND. 17 under along dye i.e., Total 65 cases. i). these 4 (23.5%) deposit (17 cases) 8 (16.6%) (48 frozen section. Which brings 18.4% (12 out cases). ii). These 12 Axillary dissection. Final HPE study 100% deposits. iii). Remaining 53 a period months. local or recurrence could be observed underwent without Short term results very promising holds strong future perspective.